Not applicableNot Yet RecruitingNCT07014709What this trial is testingImpact of GLP-1 Receptor Agonists on Patients With IPMNWho this might be right forIPMNIPMN, PancreaticGLP-1+2 more Hôpital Fribourgeois 30
Early research (Phase 1)Not Yet RecruitingNCT07140055What this trial is testingA Research Study to Evaluate BLX-7006 in Healthy AdultsWho this might be right forNormal Healthy VolunteerSafety After Oral Intake Biolexis Therapeutics 76
Not applicableStudy completedNCT06236672What this trial is testingImpact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney DiseaseWho this might be right forType 2 DiabetesChronic Kidney Diseases LMC Diabetes & Endocrinology Ltd. 348
Testing effectiveness (Phase 2)Study completedNCT06693843What this trial is testingA Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related ComorbidityWho this might be right forObesity, Overweight, or Chronic Weight Management Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 230
Large-scale testing (Phase 3)Study completedNCT04039503What this trial is testingTirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without MetforminWho this might be right forType 2 Diabetes Eli Lilly and Company 475
Not applicableActive Not RecruitingNCT07649759What this trial is testingMindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of ObesityWho this might be right forObesity & OverweightEmotional Eating BehaviourMindful Eating Intervention Bern University of Applied Sciences 40
Not applicableNot Yet RecruitingNCT07770737What this trial is testingCardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus (T2DM)Cardiovascular DiseasesStage B Heart Failure Dongtan Sacred Heart Hospital 100
Post-approval studies (Phase 4)Study completedNCT03101930What this trial is testingCardiovascular Effects of GLP-1 Receptor ActivationWho this might be right forObesityPreDiabetes Vanderbilt University Medical Center 329
Post-approval studies (Phase 4)Study completedNCT02639130What this trial is testingGLP-1 Mediating DPP-4 Inhibition in Type 2 DiabetesWho this might be right forType 2 Diabetes Diabeteszentrum Bad Lauterberg im Harz 67
Large-scale testing (Phase 3)Not Yet RecruitingNCT07021937What this trial is testingBrain Plasticity and GLP-1 Receptor Agonist Treatment for ObesityWho this might be right forObesity/Therapy University of Colorado, Denver 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07676331What this trial is testingClinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA TrialWho this might be right forHormone-receptor-positive Breast CancerEarly Breast Cancer Universitaire Ziekenhuizen KU Leuven 168
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630454What this trial is testingTirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEFWho this might be right forAtrial FibrillationHeart Failure With Preserved Ejection Fraction (HFpEF)Tirzepatide Yunlong Wang 602
Early research (Phase 1)Looking for participantsNCT07693426What this trial is testingPhase Ib Study of Efsubaglutide Alfa Injection in Obese AdolescentsWho this might be right forAdolescence Obesity Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 36
Not applicableStudy completedNCT07513259What this trial is testingPre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 DiabetesWho this might be right forObesity & OverweightDiabetes Mellitus Type 2Neoplasms Chung Shan Medical University 203,424
Testing effectiveness (Phase 2)Study completedNCT05920889What this trial is testingGlucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion TherapiesWho this might be right forStrokeStroke, AcuteStroke, Ischemic+1 more Chinese University of Hong Kong 140
Early research (Phase 1)Study completedNCT03350191What this trial is testingA Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus PatientsWho this might be right forType 2 Diabetes Mellitus Sanofi 13
Testing effectiveness (Phase 2)Looking for participantsNCT06903923What this trial is testingBone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist TherapyWho this might be right forObesity in ChildrenBone StrengthGLP - 1+3 more University of Virginia 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05254314What this trial is testingGlucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)Who this might be right forAsthma Vanderbilt University Medical Center 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07738276What this trial is testingEvaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityWho this might be right forHeart Failure and Reduced Ejection FractionObesity & OverweightTirzepatide Shahid Beheshti University of Medical Sciences 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07179120What this trial is testingCan Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm HealthWho this might be right forObesity-related Male Infertility First Affiliated Hospital of Wenzhou Medical University 180